ADMA Biologics competitors

ADMA Biologics's competitors include Mast Therapeutics, Sucampo Pharmaceuticals, Clinigen Group and Amicus Therapeutics
Add company...
ADMA Biologics
ADMA Biologics develops plasma-based biologics for the treatment and prevention of certain infectious diseases.
Mast Therapeutics
A San Diego-based biopharmaceutical company.
Sucampo Pharmaceuticals
Sucampo is a global biopharmaceutical company focused on the development and commercialization of medicines based on prostones, to meet the major unmet medical needs of patients on a global basis.
Clinigen Group
A specialty pharmaceutical and services company with a unique business model dedicated to delivering the right drug to the right patient at the right time
Amicus Therapeutics
Amicus Therapeutics is a biopharmaceutical company developing therapies for the treatment of rare and orphan diseases.
Founding Date
Founding Date
2004
Founding Date
1995
Founding Date
1996
Founding Date
2010
Founding Date
2002
Type
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Ramsey, US HQ
Boca Raton, US
Locations
San Diego, US HQ
Locations
Rockville, US HQ
Kita Ward, JP
Chiyoda, JP
Chuo Ward, JP
Sanda Shi, JP
Zug, CH
Milton, GB
Locations
Burton upon Trent, GB HQ
Locations
Cranbury Township, US HQ
Puteaux, FR
Munich, DE
Amsterdam, NL
Denham, GB
Employees
Employees
92
Employees
14133% increase
Employees
139
Employees
465200% increase
Employees
263
Valuation ($)
Valuation ($)
285 m
Valuation ($)
358.7 m
Valuation ($)
1.2 b
Valuation ($)
1.8 b
Valuation ($)
2.3 b
Twitter followers
Twitter followers
N/A
Twitter followers
873
Twitter followers
242
Twitter followers
1.2 k
Twitter followers
793

Financial

Revenue (est.)
Revenue (est.)
$10.7m (FY, 2016)
Revenue (est.)
N/A
Revenue (est.)
$230.1m (FY, 2016)
Revenue (est.)
£302.3m (FY, 2017)
Revenue (est.)
$36.9m (FY, 2017)
Cost of goods
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
$76m (FY, 2016)
Cost of goods
£179.6m (FY, 2017)
Cost of goods
$6.2m (FY, 2017)
Gross profit
Gross profit
N/A
Gross profit
N/A
Gross profit
$154.1m (FY, 2016)
Gross profit
£122.7m (FY, 2017)
Gross profit
$30.7m (FY, 2017)
Net income
Net income
($19.5m) (FY, 2016)
Net income
($29.8m) (FY, 2017)
Net income
$18.5m (FY, 2016)
Net income
£3.8m (FY, 2017)
Net income
N/A

Funding

Total funding raised
Total funding raised
$ 20m
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
$ 88m
For sources of this data, please see the company profileDownload Excel

View company profiles

Mast Therapeutics
HQ
San Diego, US
Employees
14

A San Diego-based biopharmaceutical company.

View company
Sucampo Pharmaceuticals
HQ
Rockville, US
Employees
139

Sucampo is a global biopharmaceutical company focused on the development and commercialization of medicines based on prostones, to meet the major unmet medical needs of patients on a global basis.

View company
Clinigen Group
HQ
Burton upon Trent, GB
Employees
465

A specialty pharmaceutical and services company with a unique business model dedicated to delivering the right drug to the right patient at the right time

View company
Amicus Therapeutics
HQ
Cranbury Township, US
Employees
263

Amicus Therapeutics is a biopharmaceutical company developing therapies for the treatment of rare and orphan diseases.

View company